n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Diabetes Mellitus, Type 2 in 2 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Przygodzki, T | 1 |
| Talar, M | 1 |
| Przygodzka, P | 1 |
| Watala, C | 1 |
| Guo, Z | 1 |
| Su, W | 1 |
| Allen, S | 1 |
| Pang, H | 1 |
| Daugherty, A | 1 |
| Smart, E | 1 |
| Gong, MC | 1 |
2 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Inhibition of cyclooxygenase-2 causes a decrease in coronary flow in diabetic mice. The possible role of PGE2 and dysfunctional vasodilation mediated by prostacyclin receptor.
Topics: Animals; Coronary Vessels; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diabetes Mellitus, Type 2; | 2015 |
COX-2 up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice.
Topics: Animals; Cyclooxygenase 2; Diabetes Mellitus, Type 2; Female; Gene Expression Profiling; Mice; Mice, | 2005 |